Daily News Analysis

Research linked Incentive scheme

stylish_lining

Research linked Incentive scheme

Why in the News?

The Ministry of Science and Technology has written to the Finance Ministry to introduce a Research Linked Incentive (RLI) scheme for the Pharma sector in the upcoming budget of 2024-25.

What is Research linked Incentive scheme?

  1. The RLI scheme has been envisaged on the lines of production-linked incentive (PLI) scheme, to give stimulus to research and development in the field of Science and Technology (S&T).
  2.  The incentives provided to the companies shall total an outlay of Rs. 100 Crore per year, with incremental annual spending in the forthcoming years.
  3. RLI also incorporates policy interventions to harness India’s inherent potential.
  4. The scheme shall operate in addition to the existing incentive R&D schemes available for the Pharma and biotech companies operating in India.

Possible benefits of the scheme:

  1. The incentives provided by the scheme shall enable firm push to Research and development to boost Innovation, that can help to improve India’s ranking in the Global innovation Index (GII) further.

 

 

 

 

  1. Promotes innovation in emerging fields of S&T:
    1. Electric vehicles (EV)
    2. Hydrogen and renewable energy
    3. Sustainable technologies
    4. Artificial intelligence (AI) based smart technologies involving Machine Learning
    5. Semiconductor designing and manufacturing.
  2. Research-linked incentives given sector-specific enables development of sustainable and green technologies in the future.
  3. The scheme shall enable India to shift away from a low-value, high-volume player to a high-value, high-volume player in the global pharma market.

About:

Research & Development in the Pharma sector:

  1. The Pharma R&D processes involves:
    1. Pre-clinical research
    2. Discovery of innovative drugs
    3. Clinical trials of prescription drugs
    4. Preparation and submission of applications for Food and Drug Administration or FDA approval
    5. Designing production processes for the new product
    6. Clinical testing of a new drug against an existing drug to showcase the benefits of the new drug.
    7. Additional clinical trials after a new drug reaches the market
      1. for safety monitoring
      2. Detection of additional side effects that may not have been observed in earlier trials during development
    8. Improvements over existing prescription drugs by developing new dosages and delivery systems and testing for additional potential uses
  2. India’s R&D in Pharma sector:
    1. The gestation period for translation of concept to market may take about 10-15 years, with a >90% attrition rate in the Indian pharma industry.
    2. The need for a early innovation and a cushion for handling the risk of capital needs given the high failure rate stresses the importance of incentives in R&D sector in India.
    3. The average pharma industry funding continues to be around 10%, compared to 15-20% for most large innovators globally. 
    4. Though government grants are provided especially from BIRAC (e.g., the Biotechnology Ignition Grant) and MeiTY, which accounts for about Rs 5-50 lakhs over 6-18 months, it remains largely insufficient for the entire development cycle of drugs.
    5. The R&D Expenditure of India stands at 0.8% of the GDP, way lower than the developed and emerging economies of the world.

 

 
 


UNESCO: R&D intensity as a percentage of GDP (2018)

 

 

 

India's Criminal Justice System

The recent acquittal of the 12 men convicted in the Mumbai Train Blast Case (2006) by the Bombay High Court has reignited debate over the effectiveness and integrity of India's criminal justic
Share It

India's Aviation Safety

The preliminary report of the Air India Boeing 787 crash in Ahmedabad by the Aircraft Accident Investigation Bureau (AAIB) remains inconclusive, raising troubling questions about the pilot's i
Share It

Antimicrobial Resistance

India’s steps to regulate the use of antibiotics in food animal production reflect a growing global consensus on the need to address Antimicrobial Resistance (AMR). The potential consequence
Share It

solar energy potential

India’s push toward leveraging its vast solar energy potential represents a critical strategy for accelerating the transition to net-zero emissions by 2070, as part of its long-term climate
Share It

submarine cables

The issue of securing submarine cables is increasingly being recognized as a sovereign imperative in today's data-driven world. Subsea cables are crucial infrastructure for global communicatio
Share It

STEM

The gender gap in STEM is a critical issue that continues to impede the full realization of India's potential in the global knowledge economy. Despite the notable strides in educational achiev
Share It

ASEAN

India's strategic engagement with the Association of Southeast Asian Nations (ASEAN) is vital for its economic, technological, and geopolitical positioning in a rapidly changing global landsca
Share It

State Finances and Budgets in India:

State finances play a crucial role in shaping India's broader economic landscape. With India’s federal structure, states not only drive local governance priorities but also contribute si
Share It

India’s Role in the Global Medical Workforce

India has long been a key supplier of skilled medical professionals to the global market, providing healthcare workers to countries in the Global North. However, while India excels in the export o
Share It

Critical Minerals

As the 21st century is increasingly defined by technology-driven advancements, critical minerals have emerged as one of the most significant geo economic assets. India, while a global powerhouse i
Share It

Newsletter Subscription


ACQ IAS
ACQ IAS